THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM WITH HIGH AND INTERMENDIATE RISK OF EARLY DEATH. PART 1. MORTALITY ANDCOMPLICATIONS

THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM WITH HIGH AND INTERMENDIATE RISK OF EARLY DEATH. PART 1. MORTALITY ANDCOMPLICATIONS

Background The advantages of thrombolytic therapy over anticoagulant therapy in the treatment of acute pulmonary embolism are uncertain. Aim of study To compare primary outcomes and incidence of complications in patients with PE of high and intermediate risk in the course of TLT or ACT and to assess...

Full description

Bibliographic Details
Main Authors: O. V. Nikitina, I. P. Mikhailov, D. A. Kosolapov, V. I. Avfukov, E. A. Ostrogina, S. N. Kuznetsov, T. N. Cherkashina, N. I. Mirda
Format: Article
Language:Russian
Published: Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2018-04-01
Series:Neotložnaâ Medicinskaâ Pomoŝʹ
Subjects:
pulmonary embolism
thrombolytic therapy
anticoagulant therapy
intermediate risk of adverse outcome
mortality rate
intracranial hemorrhages
cardiac arrhythmias
Online Access:https://www.jnmp.ru/jour/article/view/433

Internet

https://www.jnmp.ru/jour/article/view/433

Similar Items